sefulness of contrast-enhanced ultrasonography with Sonazoid for diagnosis and liver function assessment for Non-alcoholic steatohepatitis (NASH).
Not Applicable
- Conditions
- non-alcoholic fatty liver diseaseNAFLD
- Registration Number
- JPRN-UMIN000014400
- Lead Sponsor
- Faculty of Medicine, University of Tsukuba, Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Under 18 years old. History of allergy to ingredients of this agent. Allergy to eggs or dairy products. Arteriovenous shunt at heart or lung. Heart disease. Lung disease. Disagree with participation in this investgation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ASH is efficiently picked up from the patient population of a non-alcoholic fatty liver.
- Secondary Outcome Measures
Name Time Method